Invention Application
- Patent Title: COMPOSITIONS FOR INHIBITING UBIQUITIN SPECIFIC PROTEASE 1
-
Application No.: US17417805Application Date: 2019-12-27
-
Publication No.: US20220073525A1Publication Date: 2022-03-10
- Inventor: Alexandre Joseph Buckmelter , Justin Andrew Caravella , Jian Lin , Edward L. Fritzen
- Applicant: FORMA Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: FORMA Therapeutics, Inc.
- Current Assignee: FORMA Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- International Application: PCT/US19/68648 WO 20191227
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
This disclosure relates to modulating ubiquitin specific protease 1 (USP1) and provides novel chemical compounds useful as inhibitors of USP1, as well as various uses of these compounds. USP1 inhibiting compounds are useful in the treatment of diseases and disorders associated with USP1, such as cancer.
Information query
